Viewing Study NCT03028350


Ignite Creation Date: 2025-12-24 @ 5:04 PM
Ignite Modification Date: 2025-12-29 @ 4:40 AM
Study NCT ID: NCT03028350
Status: COMPLETED
Last Update Posted: 2024-07-10
First Post: 2017-01-19
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD)
Sponsor: Cumberland Pharmaceuticals
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2017-07-17
Start Date Type: ACTUAL
Primary Completion Date: 2023-04-25
Primary Completion Date Type: ACTUAL
Completion Date: 2023-04-25
Completion Date Type: ACTUAL
First Submit Date: 2017-01-19
First Submit QC Date: None
Study First Post Date: 2017-01-23
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2024-06-05
Results First Submit QC Date: None
Results First Post Date: 2024-06-28
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-06-27
Last Update Post Date: 2024-07-10
Last Update Post Date Type: ACTUAL